Capital Fund Management (CFM)
ALT icon

Capital Fund Management (CFM)’s Altimmune ALT Stock Holding History

Capital Fund Management (CFM)’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-726,829
Closed -$4.46M – 2008
2024
Q3 		$4.46M Sell
726,829
-159,448
-18% -$1.08M 0.01% 1074
2024
Q2 		$5.89M Buy
+886,277
New +$6.54M 0.02% 877

Other funds holding ALT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Capital Fund Management (CFM)'s ALT Position: Q4 2024 in Review

Capital Fund Management (CFM) sold out of Altimmune (ALT) in Q4 2024, closing a stake of 726,829 shares — an estimated $4.46M sold.

Capital Fund Management (CFM) first reported a position in ALT in Q2 2024 and held it in 2 quarters. The position peaked at $5.89M in Q2 2024. 182 funds tracked by Wall St. Rank hold ALT as of Q4 2024.

  • Capital Fund Management (CFM) reported no remaining Altimmune position as of Q4 2024 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 726,829 Altimmune shares in Q4 2024, an estimated $4.46M.
  • Capital Fund Management (CFM) first reported a position in Altimmune in Q2 2024 and held it in 2 quarters.
  • Capital Fund Management (CFM)'s Altimmune position peaked at $5.89M in Q2 2024.
  • 182 funds tracked by Wall St. Rank held Altimmune as of Q4 2024.

Based on Capital Fund Management (CFM)'s 13F filing for Q4 2024, filed 13 Feb 2025.